Total Payments
$13,375
2024 Payments
$607.58
Companies
23
Transactions
132
Medicare Patients
12,736
Medicare Billing
$3.7M
Payment Breakdown by Category
Other$9,422 (70.4%)
Food & Beverage$3,807 (28.5%)
Travel$145.90 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,422 | 2 | 70.4% |
| Food and Beverage | $3,807 | 129 | 28.5% |
| Travel and Lodging | $145.90 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $9,656 | 11 | $0 (2024) |
| Medtronic, Inc. | $1,051 | 16 | $0 (2023) |
| Boston Scientific Corporation | $640.63 | 13 | $0 (2024) |
| Medtronic USA, Inc. | $538.64 | 11 | $0 (2020) |
| PFIZER INC. | $260.99 | 16 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $183.54 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $183.11 | 12 | $0 (2023) |
| Nuvectra Corporation | $145.90 | 1 | $0 (2017) |
| Daiichi Sankyo Inc. | $124.42 | 9 | $0 (2019) |
| SCILEX PHARMACEUTICALS INC. | $82.83 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $607.58 | 17 | Boston Scientific Corporation ($323.39) |
| 2023 | $324.98 | 14 | Medtronic, Inc. ($130.14) |
| 2022 | $478.19 | 7 | Medtronic, Inc. ($383.01) |
| 2021 | $601.12 | 12 | Medtronic, Inc. ($537.45) |
| 2020 | $603.06 | 19 | Medtronic USA, Inc. ($338.01) |
| 2019 | $249.37 | 11 | Medtronic USA, Inc. ($81.27) |
| 2018 | $388.63 | 25 | PFIZER INC. ($79.12) |
| 2017 | $10,122 | 27 | Abbott Laboratories ($9,422) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Analgesic | ||||||
| 12/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| Category: Opioid Analgesic | ||||||
| 12/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Opioid Analgesic | ||||||
| 12/05/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $144.20 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Analgesic | ||||||
| 09/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.67 | General |
| Category: Opioid Analgesic | ||||||
| 08/21/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/17/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.61 | General |
| 07/20/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Analgesic | ||||||
| 05/24/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $92.78 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/21/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Neuromodulation | ||||||
| 05/21/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Neuromodulation | ||||||
| 05/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.52 | General |
| Category: Opioid Analgesic | ||||||
| 04/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $69.68 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/07/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Neuromodulation | ||||||
| 08/04/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/28/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/15/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Opioid Analgesic | ||||||
| 06/06/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $70.45 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/19/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Analgesic | ||||||
| 05/16/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/09/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 3,463 | 10,731 | $5.9M | $1.1M |
| 2022 | 20 | 4,244 | 10,699 | $6.7M | $997,223 |
| 2021 | 21 | 2,868 | 9,131 | $4.7M | $850,314 |
| 2020 | 16 | 2,161 | 7,586 | $2.9M | $693,638 |
Total Patients
12,736
Total Services
38,147
Medicare Billing
$3.7M
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 1,148 | 3,880 | $1.9M | $595,425 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 650 | 2,222 | $1.7M | $239,173 | 14.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 1,148 | 3,894 | $1.8M | $237,145 | 13.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 34 | 41 | $123,000 | $11,616 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 157 | $94,200 | $10,165 | 10.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $49,000 | $5,057 | 10.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 13 | 15 | $45,000 | $3,404 | 7.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 13 | 14 | $42,000 | $2,823 | 6.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 19 | 22 | $66,000 | $2,474 | 3.7% |
| 99452 | Telephone or internet referral service, 30 minutes | Office | 2023 | 74 | 85 | $12,750 | $2,321 | 18.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 32 | $96,000 | $2,020 | 2.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 11 | 14 | $42,000 | $1,393 | 3.3% |
| 80505 | Pathology clinical consultation for complex clinical problem, 41-60 minutes | Office | 2023 | 13 | 13 | $2,031 | $1,072 | 52.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 29 | 48 | $2,400 | $247.65 | 10.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 33 | 119 | $2,380 | $98.98 | 4.2% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 60 | 83 | $830.00 | $10.03 | 1.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 14 | 57 | $4,275 | $4.82 | 0.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 712 | 3,617 | $2.7M | $374,193 | 13.8% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 785 | 1,893 | $946,500 | $291,508 | 30.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 804 | 2,250 | $1.0M | $137,287 | 13.6% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 219 | 347 | $378,200 | $35,673 | 9.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 246 | 246 | $344,400 | $33,453 | 9.7% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 159 | 189 | $217,350 | $20,054 | 9.2% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 159 | 188 | $141,000 | $14,552 | 10.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 161 | 195 | $136,500 | $14,214 | 10.4% |
About Dr. Tristan Shockley, MD
Dr. Tristan Shockley, MD is a Physical Medicine & Rehabilitation healthcare provider based in Laurel, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932242542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tristan Shockley, MD has received a total of $13,375 in payments from pharmaceutical and medical device companies, with $607.58 received in 2024. These payments were reported across 132 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,422).
As a Medicare-enrolled provider, Shockley has provided services to 12,736 Medicare beneficiaries, totaling 38,147 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation
- Location Laurel, MD
- Active Since 02/14/2007
- Last Updated 06/30/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1932242542
Products in Payments
- INTELLIS (Device) $843.67
- INTELLIS ADAPTIVESTIM (Device) $341.65
- WaveWriter Alpha Prime 16 (Device) $323.39
- LYRICA (Drug) $240.08
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $171.50
- SPECTRA WAVEWRITER (Device) $166.14
- Algovita (Device) $145.90
- GENERAL - PAIN MANAGEMENT (Device) $131.29
- RELISTOR (Drug) $130.90
- XTAMPZA (Drug) $111.65
- RELISTOR ORAL (Drug) $102.81
- RESTORE (Device) $99.51
- PROCLAIM (Device) $94.76
- ZTLido (Drug) $82.83
- Morphabond ER (Drug) $72.61
- OCTRODE (Device) $69.93
- Belbuca (Drug) $55.98
- BELBUCA (Drug) $55.95
- Vanta (Device) $55.54
- UBRELVY (Drug) $51.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.